Clinical Trial Update: Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing hypofractionated radiation therapy to standard radiation therapy for ductal carcinoma in situ or early invasive breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ
• Invasive Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-11-19